BR9810135A - Composto intermediário carbapenem estabilizado, e, processo para sintetizar um composto - Google Patents

Composto intermediário carbapenem estabilizado, e, processo para sintetizar um composto

Info

Publication number
BR9810135A
BR9810135A BR9810135-8A BR9810135A BR9810135A BR 9810135 A BR9810135 A BR 9810135A BR 9810135 A BR9810135 A BR 9810135A BR 9810135 A BR9810135 A BR 9810135A
Authority
BR
Brazil
Prior art keywords
compound
synthesizing
carbapenem intermediate
stabilized carbapenem
intermediate compound
Prior art date
Application number
BR9810135-8A
Other languages
English (en)
Inventor
John M Williams
Karel M J Brands
Renato T Skerlj
Ulf H Dolling
Ronald B Jobson
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719383.3A external-priority patent/GB9719383D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BR9810135A publication Critical patent/BR9810135A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"COMPOSTO INTERMEDIáRIO CARBAPENEM ESTABILIZADO, E, PROCESSO PARA SINTETIZAR UM COMPOSTO". é divulgado composto intermediário carbapenem estabilizado representado pela fórmula (I): ou um sal do mesmo, onde P representa um grupo protetor carboxila e X representa um grupo balanceador de cargas. Além disso é divulgado um processo para sintetizar um composto representado pela fórmula (2): onde X^ +^ é um grupo balanceador de cargas, e que compreende: desproteger um composto com a fórmula (1) para produzir um composto (2).
BR9810135-8A 1997-06-16 1998-06-12 Composto intermediário carbapenem estabilizado, e, processo para sintetizar um composto BR9810135A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4964097P 1997-06-16 1997-06-16
GBGB9719383.3A GB9719383D0 (en) 1997-09-11 1997-09-11 Stabilized carbapenem intermediates and improved process for carbapenem synthesis
PCT/US1998/012339 WO1998057973A1 (en) 1997-06-16 1998-06-12 Stabilized carbapenem intermediates and synthetic use

Publications (1)

Publication Number Publication Date
BR9810135A true BR9810135A (pt) 2000-08-08

Family

ID=26312229

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810135-8A BR9810135A (pt) 1997-06-16 1998-06-12 Composto intermediário carbapenem estabilizado, e, processo para sintetizar um composto

Country Status (20)

Country Link
EP (1) EP0991651B1 (pt)
JP (1) JP3245427B2 (pt)
KR (1) KR100364339B1 (pt)
CN (1) CN1105719C (pt)
AT (1) ATE254127T1 (pt)
AU (1) AU726882B2 (pt)
BR (1) BR9810135A (pt)
CA (1) CA2293835C (pt)
DE (1) DE69819727T2 (pt)
DK (1) DK0991651T3 (pt)
EA (1) EA001926B1 (pt)
ES (1) ES2210773T3 (pt)
HU (1) HUP0004243A3 (pt)
NZ (1) NZ500955A (pt)
PL (1) PL337016A1 (pt)
PT (1) PT991651E (pt)
SK (1) SK179799A3 (pt)
UA (1) UA58469C2 (pt)
WO (1) WO1998057973A1 (pt)
YU (1) YU65899A (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548492B1 (en) * 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
WO2001032172A1 (en) * 1999-10-29 2001-05-10 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
US20040198973A1 (en) * 2001-08-13 2004-10-07 Tsujii Masahiko Process for preparation of carbapenem antibiotics
EP1686129A1 (de) * 2004-08-18 2006-08-02 Sandoz AG Carbapenem-Verbindungen, ihre Herstellung und Verwendung in Synthese von Carbapenemen
CN100582106C (zh) * 2006-01-27 2010-01-20 上海医药工业研究院 一种吡咯烷硫基碳青霉烯衍生物的制备方法及其中间体
CN101328179B (zh) * 2007-06-15 2011-01-12 山东轩竹医药科技有限公司 含有氧代氮杂环的巯基吡咯烷培南衍生物
CN101367804B (zh) * 2007-06-26 2010-12-15 山东轩竹医药科技有限公司 含有金刚烷的培南衍生物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
EP2505190A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Polymorphic forms of ertapenem monosodium salt and process for it's preparation
US20130079322A1 (en) * 2010-05-21 2013-03-28 Xuanzhu Pharama Co., Ltd. Crystalline of carbapenem derivative or its hydrate, preparation methods and uses thereof
AU2013328585A1 (en) 2012-10-12 2015-04-09 Sandoz Ag Preparation of ertapenem intermediates
WO2014085471A1 (en) * 2012-11-28 2014-06-05 Prognosdx Health, Inc. Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation
CN103537192A (zh) * 2013-10-25 2014-01-29 上海珺领生化科技有限公司 一种提纯、浓缩厄他培南水溶液的膜集成装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation

Also Published As

Publication number Publication date
SK179799A3 (en) 2000-09-12
WO1998057973A1 (en) 1998-12-23
EA200000030A1 (ru) 2000-06-26
EP0991651B1 (en) 2003-11-12
PL337016A1 (en) 2000-07-31
EA001926B1 (ru) 2001-10-22
UA58469C2 (uk) 2003-08-15
NZ500955A (en) 2001-06-29
PT991651E (pt) 2004-03-31
EP0991651A1 (en) 2000-04-12
EP0991651A4 (en) 2001-06-13
DE69819727T2 (de) 2004-09-23
HUP0004243A2 (en) 2001-03-28
CN1105719C (zh) 2003-04-16
AU8142998A (en) 1999-01-04
HUP0004243A3 (en) 2001-12-28
KR100364339B1 (ko) 2002-12-18
ATE254127T1 (de) 2003-11-15
YU65899A (sh) 2001-05-28
KR20010013774A (ko) 2001-02-26
DE69819727D1 (de) 2003-12-18
CA2293835A1 (en) 1998-12-23
CA2293835C (en) 2003-09-16
DK0991651T3 (da) 2004-03-08
JP2000511206A (ja) 2000-08-29
CN1259949A (zh) 2000-07-12
ES2210773T3 (es) 2004-07-01
AU726882B2 (en) 2000-11-23
JP3245427B2 (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
BR9810135A (pt) Composto intermediário carbapenem estabilizado, e, processo para sintetizar um composto
AU7001596A (en) Compounds potentiating retinoid
EP1090908A3 (en) Cyclobutane derivatives as inhibitors of protein farnesyltransferase
CO4950594A1 (es) Emulsiones para apresto
AU5993896A (en) Semicarbazones having cns activity and pharmaceutical preparations containing same
CA2354774A1 (en) Farnesyl protein transferase inhibitors
HRP20030566B1 (en) Improved process for carbapenem synthesis
BR9612341A (pt) Processo para preparar 2,4-diidróxipiridina.
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
DE69429642D1 (de) Lactol-Derivate, als Cathepsin L Inhibitoren
ES2144034T3 (es) Composiciones farmaceuticas estables que contienen alfa-interferon hibrido.
BR9914780A (pt) Processo de preparação de um composto defórmula (i) e composto produzido através de talprocesso
ATE209205T1 (de) Indan-2-mercaptoacetylamid disulfidderivate als enkephalinase inhibitoren
DE69737376D1 (de) Verfahren zur Synthese einer Oxonolverbindung
BR9809809A (pt) Processo para a preparação de um composto, e, proxetina
PT83334B (pt) Processo para a preparacao de compostos beta-lactamicos
BR0016991A (pt) Método para sìntese de hidrozodicarbonamida
BR0009856A (pt) Sìntese de 3-amino-3-aril propanoatos
PT99331B (pt) Processo para a preparacao de 3-difenilmetoxi-8-azabiciclo{3.2.1}octilalquil-tiazolidinomas e de composicoes farmaceuticas que as contem
BR9909756A (pt) Processo para a preparação de um composto
CA2222361A1 (fr) Derives ammoniums quaternaires hydroxypropyles a fonction ester, compositions cosmetiques et dermatologiques les contenant
ATE191466T1 (de) Verfahren zur herstellung von arylalkynyl-n- hydroxyharnstoff derivate mit wirkung als lipoxygenaseinhibitoren
BR9610085A (pt) Derivados de peptìdios
ES2194866T3 (es) Procedimiento para sintetizar derivados de azetidinona sustituidos en posicion 4.
ATE206699T1 (de) Uch-15-verbindungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.